Verve Therapeutics
VERV
#6696
Rank
โ‚น43.77 B
Marketcap
โ‚น492.95
Share price
5.67%
Change (1 day)
-10.11%
Change (1 year)

P/S ratio for Verve Therapeutics (VERV)

P/S ratio as of April 2025 (TTM): 15.9

According to Verve Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.04. At the end of 2024 the company had a P/S ratio of 15.8.

P/S ratio history for Verve Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202415.8-83.47%
202395.3-84.47%
2022614
2021N/A